| The First SANTRO Symposium 2008, Grand Epoch City, Beijing, August 28-30, 2008 |  |
 |
|
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ |
The Preliminary Program (to be updated) Day 1 ( Session I: Welcome and introduction Chairs: Ken Zhen, M.D./ Fang-Fang Yin, PhD (US) Zhihao Yu MD/Yexiong Li M.D. ( 1) Welcomes: SANTRO-China (GuoLiang Jiang M.D.) SANTRO-China/CSTRO-(Jinming Yu M.D.) SANTRO-China/CACA-(Taixian Lu M.D.) 2) SANTRO Introduction and Inauguration (Feng-Ming Kong M.D. Ph.D. M.P.H.) 3) ASTRO-International Affairs (Bernard Cummings M.D.) 4) ASCO Clinical Education (Theodore S Lawrence M.D. Ph.D.) 5) ACRO Oncology Professional (James Welsh M.D.) 6) AAPM QA Tasks (Eric Klein Ph.D.) 7) NACMPA Physicist Education (Allen Li Ph.D.) 8) RRS Radiation Research (Mark Dewhirst Ph.D.) 9) RTOG Clinical Trials (Walter Curran M.D.) Session II: Radiation Oncology Practice and Clinical Trial Chairs: Zhongxing Liao, M.D./Feng-Ming Kong M.D. Ph.D. (US) JiangJi Pan M.D./Taixiang Lu M.D. ( 1) Radiation Oncology in 2) Radiation Oncology in the US/ASTRO representative (15 min) 3) Radiation Oncology in Japan/JASTRO (15 min) 4) Individualized Medicine in Oncology and Radiation Oncology (TBD 15 min) 5) Clinical Trial in Radiation Therapy (TBD 15 min) 6) To publish your work in Red Journal (James Cox M.D. 15 min) 7) To publish your work in JCO (Theodore S Lawrence M.D.Ph.D. 15 min) Lunch Educational Session: Day 1--- Meeting Professors Chairs: Ying Hitchcock, M.D., Jeff Yue Ph.D. (US) Expert Panelists: Thomas Buchholtz M.D., Eric Klein Ph.D. Chinese co-chairs TBD ( Participants: All professors, residents and junior investigators Session III: Technology in Practice and in Translation Chairs: Fang-Fang Yin Ph.D./Yue Cao, Ph.D. (US) Hongzhi Zhang, M.S./Xiaowu Deng, M.S. ( 1) Common mistakes in radiation oncology clinic (TBD M.D.20 min) 2) The basic infrastructure for quality assurance and quality control (Eric Klein Ph.D. 20 min) 3) QA for Advanced technologies (David Jaffray, Ph.D. 20 min) 4) Translating technology into clinical trials and practice (Randall Ten Haken Ph.D. 20 min) 5) Anatomic and functional imaging guided RT (Lei Xing Ph.D. 20 min) 6) Imaging for adaptive RT (Di Yan Ph.D. 20 min) 7) Functional imaging for treatment assessment (Yue Cao Ph.D.20 min) 8) 4-D imaging or Enhancing Clinical Care and Research through Informatics in Radiation Oncology (George Chen, PhD, 20 min) 9) Bridging Bio-Molecular Research with Radiation Treatment of Cancer (John Wong Ph.D. 20 min) Session IV: Translating Biology into Practice and Clinical Trial Chairs: Yi Sun, M.D., Ph.D., Zhiyuan Shen M.D. Ph.D. ( Chinese co-chairs-TBD ( 1) The basics and current advances in radiobiology (Mark Dewhirst Ph.D. 20 min) 2) Molecular guidance in individualized radiation therapy (Steven Hahn M.D. 20 min) 3) Translational research program in RTOG (Adam Dicker M.D. 20 min) 4) Combined chemotherapy with radiation: from Bench to Bedside (Theodore S Lawrence M.D., Ph.D., 20 min) 5) Targeted therapy and its combination with radiation therapy (Kian K Ang, M.D., Ph. D. 20 min) 6) Translating nanotechnology into radiation oncology (Mohamed Khan M.D., Ph.D. 20 min) 7) Molecular prognostic factors and predictors on individualized chemotherapy and radiation therapy (TBD 30 min) Session V: Cancers of Laryngnx Oropharyngx and Hypopharynx Chairs: Ken Zhen M.D., Ping Xia Ph.D. (US) Chinese co-chairs TBD ( Expert panelists: JiangJi Pan M.D., Kian K Ang M.D., Everett Vokes M.D., Ken Zhen, M.D., Ping Xia, Ph.D. CSTRO/CSCO faculty 1) The consensus and guidelines for radiation therapy in cancers of laryngnx oropharyngx and hypopharynx (Kian K Ang M.D. 20 min/CSTRO faculty 20 min) 2) The role of chemotherapy and individualized systemic therapy (Everett Vokes M.D. 15 min) 3) Interactive case presentations (CSTRO faculty 15min) and expert panel discussions (15 min) 4) IGRT, adaptive IGRT, IMRT dosimetry, and biology in laryngeal/hypopharyngeal cancer (selected scientific oral presentations 40 min) 5) The completed, ongoing and future clinical trials in laryngeal/oropharyngeal/hypopharyngeal cancers (Kian K Ang M.D. 15 min) 6) Technical considerations of advanced treatment techniques for laryngeal/hypopharyngeal cancers (TBD 15 min) Quality of life and salivatory gland protection (Chris .H.J. Terhaard M.D) 7) Quality assurance of advanced treatment techniques for laryngeal/hypopharyngeal cancers (TBD 15 min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty 15min) Session VI: Nasopharyngeal Cancer (NPC) Chairs: Jiade Lu M.D., John Wong Ph.D. (US) Chinese co-chairs TBD ( Expert panelists: Taixiang Lu M.D., Harry Quon M.D., Jiade Lu M.D., Ph.D. John Wong PhD, 1) The consensus and guidelines on the management of nasopharyngeal cancer (TBD. 20 min/ CSTRO faculty 20 min) 2) The role of chemotherapy and individualized systemic therapy in NPC (Everett Vokes M.D.15min) 3) Interactive case presentations and expert panel discussions (TBD 30 min) 4) IGRT, adaptive IGRT, IMRT dosimetry, and biology in nasopharyngeal cancer (selected scientific oral presentations 40 min) 5) The completed, ongoing and future clinical trials in nasopharyngeal cancer (Harry Quon M.D. 15 min) 6) Multi-institutional prospective studies on nasopharyngeal cancer by 8 Asian countries in the Forum for Nuclear Cooperation in Asia (FNCA) (Hirohiko Tsujii M.D.) 7) Technical considerations of advanced NPC treatment techniques 8) Quality assurance of advanced NPC treatment techniques (TBD 15 min) 9) Selected clinical trial concepts (CSTRO/SANTRO faculty-15 min) Session VII: Liver Cancer Chairs: Chi Lin M.D., Allen Li, Ph.D. (US) Guo Liang Jiang, M.D., Zhaochong Zhen, M.D. ( Expert Panelists: Guo Liang Jiang, M.D., Zhaochong Zhen, M.D., Chi Lin M.D., Allen Li, Ph.D. Theodore S Lawrence M.D., Ph.D., Laura Dawson M.D., Randall Ten Haken Ph.D. 1) The management of liver malignancies and the role of radiation therapy (Laura Dawson M.D. 20min/CSTRO faculty 20 min) 2) The role of chemotherapy and individualized systemic therapy in liver cancer (Laura Dawson M.D.15 min) 3) Interactive case presentations (CSTRO faculty15 min) and expert panel discussions (20 min) 4) Dose-response and motion adaptive IGRT and biology in liver cancer (selected scientific oral presentations 40min) 5) The completed and ongoing clinical trials in liver cancer (TBD 15 min) 6) Technical considerations of advanced treatment techniques for liver cancers (TBD 15 min) 7) Quality assurance of advanced treatment techniques for liver cancers (TBD 15 min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty-15 min) Lunch Session Day 2. Poster Walk and Discussions Chairs: Billy Lu M.D., Ying Hitchcock, M.D., Yan Yu, Ph.D. (US) Chinese co-chairsTBD ( Participants: Residents junior faculty and all other interested participants Session VIIIA: Non-small Cell Lung Cancer Chairs: Feng-Ming Kong M.D. Ph.D. MPH, Dong Lei Ph.D (US) Chinese co-chairs TBD ( Expert panelists: Ritsuko Komaki M.D., Everett Vokes M.D., Walter Curran M.D., Feng-Ming Kong M.D. Ph.D., MPH, Dong Lei Ph.D., Chinese TBD 1) The consensus and guidelines for radiation therapy in non-small cell lung cancer and the role of radiation therapy (Ritsuko Komaki M.D. 20 min /CSTRO faculty 20 min) 2) The role of combined chemotherapy and radiation therapy and individualized chemotherapy in lung Cancer (Everett Vokes M.D. 30 min) 3) Interactive case presentations and expert panel discussions (TBD 30 min) 4) Dose-response and motion adaptive IGRT and biology in lung cancer (selected scientific oral presentations 40 min) 5) The completed, ongoing and future clinical trials in lung cancers (Walter Curran M.D.15 min) 6) Technical considerations of advanced treatment techniques for lung cancers (TBD 15 min) 7) Quality assurance of advanced treatment techniques for lung cancers (TBD 15 min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty-15min) Session VIIIB: Small Cell Lung Cancer Chairs: Joe Chang M.D. Ph.D., Ying Xiao, Ph.D. (US) Chinese co-chairs TBD ( Expert panelists: Ritsuko Komaki M.D., Everett Vokes M.D., Joe Chang M.D. Ph.D., Ying Xiao, Ph.D., Chinese co-chairs TBD 1) The consensus and guidelines on radiation therapy in small cell lung cancer (Ritsuko Komaki M.D. 20 min/CSTRO faculty 15 min) 2) The role of combined chemotherapy and systemic therapy in esophageal Cancer (ASCO faculty- Everett Vokes M.D. 30 min) 3) Interactive case presentations (CSTRO faculty 10min) and expert panel discussions (20 min) 4) IGRT, adaptive IGRT, IMRT dosimetry, and biology in esophageal cancer (selected scientific oral presentations -40 min) 5) The completed ongoing and future clinical trials in small cell lung cancers (Branislav Jeremic M.D. Ph.D. 20 min) 6) Technical considerations of advanced treatment techniques for esophageal cancers (TBD 15 min) 7) Quality assurance of advanced treatment techniques for esophageal cancers (TBD 15 min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty-15 min) Session IX: Esophageal Cancer Chairs: Zhongxing Liao, M.D., Steve Jiang Ph.D. (US) Chinese co-chairs TBD ( Expert panelists: Christopher Willet M.D., Zhongxing Liao, M.D., Steve Jiang Ph.D., Chinese co-chairs TBD 1) The consensus and controversies on the management of esophageal cancer and the role of radiation therapy (Christopher Willet M.D. /CSTRO faculty 60 min) 2) The role of combined chemotherapy and individualized systemic therapy in esophageal Cancer (TBD 15 min) 3) Interactive case presentations and expert panel discussions (30 min) 4) IGRT, adaptive IGRT, IMRT dosimetry, and biology in esophageal cancer (selected scientific oral presentations 40 min) 5) The completed and ongoing clinical trials in esophageal cancers (Christopher Willet M.D. 20 min) 6) Technical considerations of advanced treatment techniques for esophageal cancers (TBD 15min) 7) Quality assurance of advanced treatment techniques for esophageal cancers (TBD 15min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty 15min) Session X: Gastric Cancer Chairs: Shiyu Song M.D., Lei Dong, PhD (US) Chinese co-chairs TBD ( Expert Panelists: Bernard Cummings M.D., Christopher Willet M.D., Shiyu Song M.D., David Jaffray, PhD, Chinese co-chairs TBD 1) Practice consensus and treatment recommendations for Gastric Cancer and the role of radiation therapy (Bernard Cummings M.D. 20 min/CSTRO faculty 20 min) 2) The role of combined chemotherapy and radiation therapy and individualized chemotherapy in Gastric Cancer (Bernard Cummings M.D. 15min) 3) Interactive case presentations (CSTRO faculty 10min) and expert panel discussions (20min) 4) Translational IGRT, adaptive IGRT and biology in gastric cancer (selected scientific oral presentations 40min) 5) Completed ongoing and future clinical trials in gastric cancer (Christopher Wallet M.D. 20min) 6) Technical considerations of advanced treatment techniques for gastric cancers (TBD 10min) 7) Quality assurance of advanced treatment techniques for gastric cancers (TBD 10min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty-15min) Session XI: Prostate Cancer Chairs: Dian Wang M.D., Sha Chang Ph.D. (US) Chinese co-chairs TBD ( Expert Panelists: Yexiong Li M.D. Howard Sandler M.D., Jeff Michalski M.D., Patrick McLaughlin M.D., Dian Wang M.D., Sha Chang,PhD, Yan Yu,Ph.D. Chinese co-chairs TBD 1) Practice consensus and treatment recommendations for Prostate Cancer and the role of radiation therapy (Jeff Michalski M.D. 25 min/Yexiong Li M.D. 15min) 2) Interactive case presentations and expert panel discussions (TBD 30 min) 3) Translational IGRT, adaptive IGRT and biology in GI/GU or other malignances (selected scientific oral presentations 40 min) 4) Completed ongoing and future clinical trials in GI/GU or other malignances (Howard Sandler M.D., 25 min) 5) Technical considerations of advanced treatment techniques for prostate cancers (TBD 20 min) 6) Quality assurance of advanced treatment techniques for prostate cancers (TBD 15min) 7) Methods to Improve Contouring Consensus in Prostate Cancer Treatment Planning (Patrick McLaughlin M.D. 15 min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty15min) Session XII: Breast Cancer Chairs: Bo Lu M.D. Ph.D., Jianyue Jin Ph.D. (US) Chinese co-chairs TBD ( Expert Panelists: Thomas Buchholtz M.D., George Chen, PhD, J Jin Ph.D., Chinese co-chairs TBD 1) Practice consensus and treatment recommendations for breast Cancer and the role of radiation therapy (Thomas Buchholtz M.D.20 min /CSTRO Faculty 15min) 2) Consideration of chemotherapy and systemic therapy in breast cancers (TBD 15min) 3) Interactive case presentations (CSTRO faculty 10min) and expert panel discussions (20min) 4) Translational IGRT, adaptive IGRT and biology in breast cancer and gyn malignances (selected scientific oral presentations) 4) Completed and ongoing clinical trials in breast cancer (Thomas Buchholtz M.D. 20-25min) 5) Technical considerations of advanced treatment techniques for breast cancers (TBD 15min) 6) Quality assurance of advanced treatment techniques for breast cancers (TBD 15min) 7) Selected clinical trial concepts (CSTRO/SANTRO faculty-15min) Session XIII: Gynecology Cancer Chairs: Miriam Joy C Calaguas M.D., Jeff Yue Ph.D. (US) Chinese co-chairs TBD ( Expert Panelists: Miriam Joy C Calaguas M.D., Jeff Yue Ph.D., Lee Khai Mu M.D., Hirohiko Tsujii M.D., Chinese co-chairs TBD 1) Practice consensus and treatment recommendations for Gyn Cancer and the role of radiation therapy (Lee Khai Mu M.D. 30 min /CSTRO Faculty 15min) 2) Consideration of chemotherapy and systemic therapy in Gyn cancers (TBD 15min) 3) Interactive case presentations (CSTRO faculty 10min) and expert panel discussions (20min) 4) Translational IGRT, adaptive IGRT and biology in Gyn malignances (selected scientific oral presentations) 5) Technical considerations of advanced treatment techniques for Gyn cancers (TBD 15min) 6) Quality assurance of advanced treatment techniques for Gyn cancers (TBD 15 min) 7) Multi-institutional prospective studies on locally advanced cervical cancer by 8 Asian countries in the Forum for Nuclear Cooperation in Asia (FNCA) (Hirohiko Tsujii M.D. 10 min) 8) Selected clinical trial concepts (CSTRO/SANTRO faculty-15min) Session XIV: Central Nerve Systems, Radiosurgery, Stereotactic Radiation Therapy Chairs: Christina Tsien M.D., JianYue Jin Ph.D., (US) Chinese Co-chairs: TBD ( Expert Panelists: Menish Metha, M.D., Christina Tsien M.D., Fang-Fang Yin Ph.D., Jianyue Jin, Ph.D., James Walsh M.D, Joe Chang M.D., Ph.D. 1) Treament guidelines for CNS tumors (Menish Metha, M.D. 20 min) 2) Consideration of biology and technology in body stereotactic radiosurgery (James Walsh M.D. 20min) 3) Stereotactic Radiation Therapy (SRT) (TBD 20min) 4) Advanced techniques in SRS and SBRT: frameless and noninvasive technology (TBD 20min) 5) Application of very low dose rate radiation therapy (Howard Steven M.D. 20 min) 6) Single fraction palliative radiation therapy (David Howell M.D. 10 min) 7) Selected scientific oral presentations (TBD 10-40min) 8) Clinical trial consideration (TBD 15 min) Clinical Trial Panel Discussion: Chairs: Joe Chang MD PhD, Ping Xia PhD Expert Panelists: All the session chairs and advisory board members Closing Ceremony: Yexiong Li M.D., Jinming Yu M.D.,Taixiang Lu, M.D., Guo Liang Jiang M.D., Fang-Fang Yin Ph.D., Feng-Ming Kong M.D. Ph.D. MPH Resident and Junior Faculty Award Presentations Meeting Adjourn, Symposium Evaluations
|